Article Text

Download PDFPDF
Rofecoxib did not slow progression of dementia in patients with established Alzheimer’s disease

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • * See glossary.

  • Information provided by author.

  • For correspondence: Dr C Lines, Merck Research Laboratories, Blue Bell, PA, USA.

  • Source of funding: Merck Research Laboratories.